OpGen Inc (OPGN)

[cadtime415]

Earnings Report out next Tuesday.

Not expecting any major news, but let's see how they did in regards to cutting expenses throughout the third quarter.

(This should provide us with a realistic outlook on how they are progressing during this quarter, in the same area.)

I would be looking for a cash position of around $5-$5.5M as of the end of the 3rd Quarter. If they trimmed expenses at a higher percentage than expected, maybe they will be closer to $6M, and I would be pleased with that progress.

Most likely they will need to raise more cash late in the 4th, or in early 2018. I wouldn't say if, but when. Personally I would be pleased if such action were to bring about a larger stake by Merck, and or JVen.

As of now we have dropped below the 50DMA, so we will see if we can bounce back above it, or if we are going to test the mid to low .20's. Personally I'm looking into the near future in regards to large partnerships, which will have a very positive impact on the PPS as we move forward into 2018.

I really don't think that trading OPGN short term is a good approach because of how the company is structured. Good quality management, with a solid business plan, and a fairly small OS and float, for a company in this arena. Personally I see the current PPS as a great entry point for a true investor, who is looking for minimal risk with potential large gains.

Cad